1. Home
  2. PTHL vs MGRM Comparison

PTHL vs MGRM Comparison

Compare PTHL & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • MGRM
  • Stock Information
  • Founded
  • PTHL 1998
  • MGRM 2016
  • Country
  • PTHL China
  • MGRM United States
  • Employees
  • PTHL N/A
  • MGRM N/A
  • Industry
  • PTHL
  • MGRM Medical/Dental Instruments
  • Sector
  • PTHL
  • MGRM Health Care
  • Exchange
  • PTHL Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • PTHL 65.0M
  • MGRM 73.5M
  • IPO Year
  • PTHL 2024
  • MGRM N/A
  • Fundamental
  • Price
  • PTHL $4.35
  • MGRM $2.05
  • Analyst Decision
  • PTHL
  • MGRM
  • Analyst Count
  • PTHL 0
  • MGRM 0
  • Target Price
  • PTHL N/A
  • MGRM N/A
  • AVG Volume (30 Days)
  • PTHL 150.0K
  • MGRM 122.7K
  • Earning Date
  • PTHL 11-26-2024
  • MGRM 11-14-2024
  • Dividend Yield
  • PTHL N/A
  • MGRM N/A
  • EPS Growth
  • PTHL N/A
  • MGRM N/A
  • EPS
  • PTHL N/A
  • MGRM N/A
  • Revenue
  • PTHL $572,291.00
  • MGRM $364,999.00
  • Revenue This Year
  • PTHL N/A
  • MGRM N/A
  • Revenue Next Year
  • PTHL N/A
  • MGRM N/A
  • P/E Ratio
  • PTHL N/A
  • MGRM N/A
  • Revenue Growth
  • PTHL 2.32
  • MGRM N/A
  • 52 Week Low
  • PTHL $3.32
  • MGRM $1.53
  • 52 Week High
  • PTHL $6.45
  • MGRM $4.90
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • MGRM 33.38
  • Support Level
  • PTHL N/A
  • MGRM $2.25
  • Resistance Level
  • PTHL N/A
  • MGRM $2.23
  • Average True Range (ATR)
  • PTHL 0.00
  • MGRM 0.14
  • MACD
  • PTHL 0.00
  • MGRM -0.02
  • Stochastic Oscillator
  • PTHL 0.00
  • MGRM 18.18

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: